Advanced Enzyme Technologies Share Price
297.55+1.55 (+0.52%)
-12.24% past 1 Year
Advanced Enzymes Technologies Limited is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and
Corporate filings & documents
Announcements
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 03 2026
21 hours agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 03 2026
21 hours agoPursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 02 2026
1 day agoPursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 02 2026
1 day agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 01 2026.
2 days agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 01 2026.
2 days agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 31 2026.
3 days agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 31 2026.
3 days agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 28 2026.
6 days agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 28 2026.
6 days agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 27 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 27 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 25 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 25 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 21 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 21 2026.
1 week agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 20 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 20 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 19 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 19 2026
2 weeks agoTranscript of Conference Call held on August 12 2026 for the Unaudited Financial Results for the Quarter ended June 30 2026
2 weeks agoTranscript of Conference Call held on August 12 2026 for the Unaudited Financial Results for the Quarter ended June 30 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 18 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 18 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 17 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 17 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 14 2026
2 weeks agoDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 14 2026
2 weeks agoPlease find enclosed herewith audio recording of earnings call held on August 12 2026.
3 weeks agoPlease find enclosed herewith audio recording of earnings call held on August 12 2026.
3 weeks agoBord Resolution for the Buyback
3 weeks agoBord Resolution for the Buyback
3 weeks agoPublic Announcement - BuyBack of the Equity Shares
3 weeks agoPublic Announcement - BuyBack of the Equity Shares
3 weeks agoPlease find enclosed herewith the copy of newspaper publication of extract of unaudited consolidated financial results for the quarter ended June 30 2026.
3 weeks agoPlease find enclosed herewith the copy of newspaper publication of extract of unaudited consolidated financial results for the quarter ended June 30 2026.
3 weeks agoPress Release titled Quaterly Earnings Release dated August 08 2026
3 weeks agoPress Release titled Quaterly Earnings Release dated August 08 2026
3 weeks agoEarnings Presentation for the Quarter ended June 30 2026
3 weeks agoEarnings Presentation for the Quarter ended June 30 2026
3 weeks agoApproved the Buy-Back of fully paid-up of Equity Shares of the Company via Open Market through Stock Exchanges
3 weeks agoApproved the Buy-Back of fully paid-up of Equity Shares of the Company via Open Market through Stock Exchanges
3 weeks ago1) Approved acquistion of the remaining stake of 4.28% Equity Shares from the other existing Equity Shareholders of JC Biotech Private Limited (Exisitng Subsidiary) and 2) Approved infusion of additional funds of Rs. 20 million in one or more tranches in Advanced Nutrazyme Private Limited (Wholly Owned Subsidiary) of the Company
3 weeks ago1) Approved acquistion of the remaining stake of 4.28% Equity Shares from the other existing Equity Shareholders of JC Biotech Private Limited (Exisitng Subsidiary) and 2) Approved infusion of additional funds of Rs. 20 million in one or more tranches in Advanced Nutrazyme Private Limited (Wholly Owned Subsidiary) of the Company
3 weeks agoUn-audited Financial Results for the Quarter ended June 30 2026
3 weeks agoUn-audited Financial Results for the Quarter ended June 30 2026
3 weeks ago1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 20262)Approved the Buyback of fully paid-up equity shares 3)Approved acquisition of the remaining stake of 4.28% Equity Shares from the other existing Shareholders of JC Biotech Private Limited 4) Approved infusion of additional funds not exceeding ? 20 million in one or more tranches in Advanced Nutrazyme Private Limited
3 weeks ago1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 20262)Approved the Buyback of fully paid-up equity shares 3)Approved acquisition of the remaining stake of 4.28% Equity Shares from the other existing Shareholders of JC Biotech Private Limited 4) Approved infusion of additional funds not exceeding ? 20 million in one or more tranches in Advanced Nutrazyme Private Limited
3 weeks agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
Corporate Actions
Date
Type
Details
2026-07-24
Dividend
1.35
2025-07-23
Dividend
1.2
2025-05-16
Dividend
4.0
2024-07-18
Dividend
1.1
2024-05-17
Dividend
4.0
2023-08-04
Dividend
1.0
2023-05-19
Dividend
4.0
2022-08-11
Dividend
1.0
2021-08-31
Dividend
0.9
2020-07-09
Dividend
0.6
2019-08-01
Dividend
0.6
2018-09-06
Dividend
0.5
2017-09-04
Dividend
0.4
2017-05-25
Split
10:2
Company details
Registered office
Sun- Magnetica, A Wing, 5th Floor Near L I C Service Road Louiswadi Thane Maharashtra PIN: 400604 Tel No: 022 41703200 Fax No: 022-25835159 Email: [email protected] Internet: www.advancedenzymes.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Vasant Rathi, Chairman
Mukund Kabra, Whole Time Director
Rasika Rathi, Promoter & Non-Executive Director
Pramod Kasat, Non Executive Independent Director
Vinodkumar Jajoo, Non Executive Independent Director
Sunny Sharma, Non Executive Director
Nitin Deshmukh, Non Executive Independent Director
Vandana Tilak, Non Executive Independent Director
Pradip Shah, Non Executive Independent Director
Sanjay Basantani, Company Secretary & Compliance Officer, Head - Legal
Details
BSE 540025
NSE ADVENZYMES
ISIN INE837H01020